Tumor-infiltrating lymphocyte (TIL) therapy
Drug timelines are a Plus or Pro feature.
5 regulatory and trial events tracked for Tumor-infiltrating lymphocyte (TIL) therapy, covering 2024-11-22 to 2026-02-13. Get the full timeline:
Most recent: Clinical Trial Update: TIL Therapy in cSCC and MCC [Phase 2]